Product Name

  • Name

    Nevirapine

  • EINECS 603-345-0
  • CAS No. 129618-40-2
  • Article Data17
  • CAS DataBase
  • Density 1.351 g/cm3
  • Solubility 0.1g/L(temperature not stated)
  • Melting Point 247 °C
  • Formula C15H14N4O
  • Boiling Point 415.4 °C at 760 mmHg
  • Molecular Weight 266.302
  • Flash Point 205 °C
  • Transport Information
  • Appearance white or off-white crystalline powder
  • Safety 26-36-37/39
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 129618-40-2 (Nevirapine)
  • Hazard Symbols IrritantXi
  • Synonyms 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2,3-e)(1,4)diazepin-6-one;Viramune;BIRG 0587;BI-RG-587;BI-RG-587;6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one,11-cyclopropyl-5,11-dihydro-4-methyl-;99% Nevirapine;Nevirapine [USAN:INN];BI-RG 587;BIRG 587;BIRG 0587;Viramune (TN);NVP;Nevirapine (JP14/USAN);11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido;Viramune (Nevirapine);
  • PSA 63.57000
  • LogP 2.47830

Synthetic route

N-(2-chloro-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide
133627-47-1

N-(2-chloro-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With diethylene glycol dimethyl ether; sodium hydride at 100 - 125℃; for 2.5h; Inert atmosphere;96%
Stage #1: N-(2-chloro-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide With potassium tert-butylate In diethylene glycol dimethyl ether at 100 - 110℃; for 1.5h;
Stage #2: With acetic acid In diethylene glycol dimethyl ether at 5 - 10℃; pH=6.0 - 7.0; Product distribution / selectivity;
83.39%
Stage #1: N-(2-chloro-4-methyl-3-pyridinyl)-2-(cyclopropylamino)-3-pyridinecarboxamide With potassium tert-butylate In toluene at 100 - 110℃; for 3 - 3.5h;
Stage #2: With sulfuric acid In water; toluene at 5 - 10℃; pH=1 - 7.0; Product distribution / selectivity;
79.96%
methyl 2-(cyclopropylamino)nicotinate

methyl 2-(cyclopropylamino)nicotinate

3-Amino-2-chloro-4-methylpyridine
133627-45-9

3-Amino-2-chloro-4-methylpyridine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With sodium hydride In diethylene glycol dimethyl ether at 65 - 165℃; Flow reactor; Green chemistry;96%
Multi-step reaction with 2 steps
1.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
1.2: 2 h / 55 - 65 °C / Inert atmosphere
2.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
1.2: 2 h / 60 °C
2.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
2-(Cyclopropylamino)-N-(2-methoxy-4-methyl-3-pyridinyl)-3-pyridinecarboxamide
162709-30-0

2-(Cyclopropylamino)-N-(2-methoxy-4-methyl-3-pyridinyl)-3-pyridinecarboxamide

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With pyridine; sodium hexamethyldisilazane at 90℃; for 6h;91%
2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide
133627-46-0

2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide

Cyclopropylamine
765-30-0

Cyclopropylamine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Stage #1: 2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide; Cyclopropylamine With triethylamine In toluene at 130℃; for 10h; Autoclave;
Stage #2: With sodium amide In diethylene glycol dimethyl ether at 15 - 110℃; for 2h; Temperature; Time; Reagent/catalyst; Autoclave;
86%
Stage #1: 2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide; Cyclopropylamine With calcium oxide In diethylene glycol dimethyl ether at 135 - 145℃;
Stage #2: With sodium hydride at 140℃; for 0.5 - 1h;
Stage #3: With water; acetic acid; ethyl acetate at 0 - 10℃; for 1 - 2h;
2-chloro-11-cyclopropyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one
135575-99-4

2-chloro-11-cyclopropyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In diethylene glycol dimethyl ether at 100℃; under 2585.7 Torr; for 12h; Yield given;
2-Chloronicotinoyl chloride
49609-84-9

2-Chloronicotinoyl chloride

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 87 percent / CH2Cl2 / 1.) -78 deg C, 1 h, 2.) RT, 23 h
2: 94 percent / 4 h / 140 °C
3: 67 percent / 80percent NaH / bis-(2-methoxy-ethyl) ether / 1.5 h / 185 °C
View Scheme
Multi-step reaction with 3 steps
1: 65.5 percent / pyridine / cyclohexane; dioxane / 48 h / Ambient temperature
2: 83 percent / xylene / 18 h / 110 °C
3: 67 percent / NaH / various solvent(s) / 1.5 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: pyridine / acetonitrile / 20 - 45 °C
2: calcium oxide / xylene / 140 °C
3: sodium hydrogen sulfate; copper(l) iodide; sulfuric acid; potassium tert-butylate / diethylene glycol dimethyl ether / 115 °C
View Scheme
2-chloronicotinic acid
2942-59-8

2-chloronicotinic acid

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 99 percent / thionyl chloride / 1 h / Heating
2: 87 percent / CH2Cl2 / 1.) -78 deg C, 1 h, 2.) RT, 23 h
3: 94 percent / 4 h / 140 °C
4: 67 percent / 80percent NaH / bis-(2-methoxy-ethyl) ether / 1.5 h / 185 °C
View Scheme
Multi-step reaction with 4 steps
1: potassium carbonate / N,N-dimethyl-formamide / 5 h / 60 - 65 °C
2: 5 h / 60 - 65 °C
3: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
4: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
2-chloro-3-nitro-4-methylpyridine
23056-39-5

2-chloro-3-nitro-4-methylpyridine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 98 percent / SnCl2 * 2 H2O, conc. HCl / diethyl ether / 0.33 h / Ambient temperature
2: 87 percent / CH2Cl2 / 1.) -78 deg C, 1 h, 2.) RT, 23 h
3: 94 percent / 4 h / 140 °C
4: 67 percent / 80percent NaH / bis-(2-methoxy-ethyl) ether / 1.5 h / 185 °C
View Scheme
Multi-step reaction with 4 steps
1: 75 percent / H2 / 5percent Rh/C / ethanol / 3 h / 2585.7 Torr
2: 65.5 percent / pyridine / cyclohexane; dioxane / 48 h / Ambient temperature
3: 83 percent / xylene / 18 h / 110 °C
4: 67 percent / NaH / various solvent(s) / 1.5 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: 5 h / 60 - 65 °C
2: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
3: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
3-Amino-2-chloro-4-methylpyridine
133627-45-9

3-Amino-2-chloro-4-methylpyridine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 87 percent / CH2Cl2 / 1.) -78 deg C, 1 h, 2.) RT, 23 h
2: 94 percent / 4 h / 140 °C
3: 67 percent / 80percent NaH / bis-(2-methoxy-ethyl) ether / 1.5 h / 185 °C
View Scheme
Multi-step reaction with 3 steps
1: 65.5 percent / pyridine / cyclohexane; dioxane / 48 h / Ambient temperature
2: 83 percent / xylene / 18 h / 110 °C
3: 67 percent / NaH / various solvent(s) / 1.5 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: pyridine / acetonitrile / 20 - 45 °C
2: calcium oxide / xylene / 140 °C
3: sodium hydrogen sulfate; copper(l) iodide; sulfuric acid; potassium tert-butylate / diethylene glycol dimethyl ether / 115 °C
View Scheme
2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide
133627-46-0

2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 94 percent / 4 h / 140 °C
2: 67 percent / 80percent NaH / bis-(2-methoxy-ethyl) ether / 1.5 h / 185 °C
View Scheme
Multi-step reaction with 2 steps
1: 83 percent / xylene / 18 h / 110 °C
2: 67 percent / NaH / various solvent(s) / 1.5 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: calcium oxide / xylene / 140 °C
2: sodium hydrogen sulfate; copper(l) iodide; sulfuric acid; potassium tert-butylate / diethylene glycol dimethyl ether / 115 °C
View Scheme
tert-butyl methyl ether
1634-04-4

tert-butyl methyl ether

2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide
133627-46-0

2-chloro-N-(2-chloro-4-methyl-3-pyridinyl)-3-pyridinecarboxamide

Cyclopropylamine
765-30-0

Cyclopropylamine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
In ethanol; diethylene glycol dimethyl ether; cyclohexane; water; acetic acid
In diglyme (diethylene glycol-dimethylether); ethanol; diethylene glycol dimethyl ether; cyclohexane; water; acetic acid
Reaxys ID: 19829874

Reaxys ID: 19829874

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With strong base
2-chloro-4-methyl-3-pyridinecarbonitrile
65169-38-2

2-chloro-4-methyl-3-pyridinecarbonitrile

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sulfuric acid / 1.25 h / 40 - 105 °C
1.2: 70 - 75 °C
2.1: sodium hydroxide; bromine / toluene; water / 0 - 60 °C
3.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
3.2: 2 h / 55 - 65 °C / Inert atmosphere
4.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: sulfuric acid / water / 8.25 h / 40 - 105 °C
2: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
3: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 4 steps
1.1: sulfuric acid / water / 8.25 h / 40 - 105 °C
2.1: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
3.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
3.2: 2 h / 60 °C
4.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
2-chloro-4-methyl-3-pyridinecarboxamide
152362-01-1

2-chloro-4-methyl-3-pyridinecarboxamide

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium hydroxide; bromine / toluene; water / 0 - 60 °C
2.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
2.2: 2 h / 55 - 65 °C / Inert atmosphere
3.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1.1: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
2.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
2.2: 2 h / 60 °C
3.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
2-chloro-3-pyridinecarbonitrile
6602-54-6

2-chloro-3-pyridinecarbonitrile

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: triethylamine / water; isopropyl alcohol / 140 °C / 517.16 - 3102.97 Torr / Inert atmosphere
2.1: water; potassium hydroxide / isopropyl alcohol / 12 h / 80 °C
3.1: thionyl chloride / toluene / 0.58 h / 20 - 50 °C / Inert atmosphere
3.2: 40 - 50 °C
4.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
4.2: 2 h / 55 - 65 °C / Inert atmosphere
5.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1.1: triethylamine / water; isopropyl alcohol / 6 h / 140 °C / 517.16 - 3102.97 Torr / Inert atmosphere
2.1: potassium hydroxide / 12 h / 20 - 40 °C
3.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
3.2: 2 h / 50 °C / Inert atmosphere
4.1: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 5 steps
1.1: triethylamine / water; isopropyl alcohol / 6 h / 140 °C / 517.16 - 3102.97 Torr / Inert atmosphere
2.1: potassium hydroxide / 12 h / 20 - 40 °C
3.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
3.2: 2 h / 50 °C / Inert atmosphere
4.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
4.2: 2 h / 60 °C
5.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
2-(cyclopropylamino)pyridine-3-carboxylic acid
639807-18-4

2-(cyclopropylamino)pyridine-3-carboxylic acid

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: thionyl chloride / toluene / 0.58 h / 20 - 50 °C / Inert atmosphere
1.2: 40 - 50 °C
2.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
2.2: 2 h / 55 - 65 °C / Inert atmosphere
3.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
1.2: 2 h / 50 °C / Inert atmosphere
2.1: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 3 steps
1.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
1.2: 2 h / 50 °C / Inert atmosphere
2.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
2.2: 2 h / 60 °C
3.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
Multi-step reaction with 3 steps
1: 5 h / 60 - 65 °C
2: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
3: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
2-cyclopropylaminonicotinonitrile
52583-90-1

2-cyclopropylaminonicotinonitrile

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: water; potassium hydroxide / isopropyl alcohol / 12 h / 80 °C
2.1: thionyl chloride / toluene / 0.58 h / 20 - 50 °C / Inert atmosphere
2.2: 40 - 50 °C
3.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
3.2: 2 h / 55 - 65 °C / Inert atmosphere
4.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1.1: potassium hydroxide / 12 h / 20 - 40 °C
2.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
2.2: 2 h / 50 °C / Inert atmosphere
3.1: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 4 steps
1.1: potassium hydroxide / 12 h / 20 - 40 °C
2.1: thionyl chloride / toluene / 0.5 h / 20 - 50 °C / Inert atmosphere
2.2: 2 h / 50 °C / Inert atmosphere
3.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
3.2: 2 h / 60 °C
4.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
2-(4-(dimethylamino)but-3-en-2-ylidene)malononitrile
71493-72-6

2-(4-(dimethylamino)but-3-en-2-ylidene)malononitrile

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: hydrogenchloride / 2 h / 50 - 55 °C
2.1: sulfuric acid / 1.25 h / 40 - 105 °C
2.2: 70 - 75 °C
3.1: sodium hydroxide; bromine / toluene; water / 0 - 60 °C
4.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
4.2: 2 h / 55 - 65 °C / Inert atmosphere
5.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: hydrogenchloride / toluene / 20 - 55 °C
2: sulfuric acid / water / 8.25 h / 40 - 105 °C
3: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
4: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 5 steps
1.1: hydrogenchloride / toluene / 20 - 55 °C
2.1: sulfuric acid / water / 8.25 h / 40 - 105 °C
3.1: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
4.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
4.2: 2 h / 60 °C
5.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
isopropylidenemalonodinitrile
13166-10-4

isopropylidenemalonodinitrile

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: triethylamine; acetic anhydride / toluene / 2 h / 5 - 20 °C / Inert atmosphere
2.1: hydrogenchloride / 2 h / 50 - 55 °C
3.1: sulfuric acid / 1.25 h / 40 - 105 °C
3.2: 70 - 75 °C
4.1: sodium hydroxide; bromine / toluene; water / 0 - 60 °C
5.1: sodium hydride / 3.5 h / 30 - 60 °C / Inert atmosphere
5.2: 2 h / 55 - 65 °C / Inert atmosphere
6.1: sodium hydride; diethylene glycol dimethyl ether / 2.5 h / 100 - 125 °C / Inert atmosphere
View Scheme
Multi-step reaction with 5 steps
1.1: acetic anhydride / toluene / 5 - 10 °C / Inert atmosphere
1.2: 2 h / 5 - 20 °C / Inert atmosphere
2.1: hydrogenchloride / toluene / 20 - 55 °C
3.1: sulfuric acid / water / 8.25 h / 40 - 105 °C
4.1: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
5.1: sodium hydride / diethylene glycol dimethyl ether / 65 - 165 °C / Flow reactor; Green chemistry
View Scheme
Multi-step reaction with 6 steps
1.1: acetic anhydride / toluene / 5 - 10 °C / Inert atmosphere
1.2: 2 h / 5 - 20 °C / Inert atmosphere
2.1: hydrogenchloride / toluene / 20 - 55 °C
3.1: sulfuric acid / water / 8.25 h / 40 - 105 °C
4.1: sodium hydroxide; bromine / water / 2 h / 0 - 20 °C
5.1: sodium hydride / diethylene glycol dimethyl ether / 0.5 h / 20 °C
5.2: 2 h / 60 °C
6.1: sodium hydride / diethylene glycol dimethyl ether / 4 h / 105 - 117 °C / Green chemistry
View Scheme
3-amino-4-methylpyridine
3430-27-1

3-amino-4-methylpyridine

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: hydrogenchloride; dihydrogen peroxide / water / 20 °C
1.2: pH 8
2.1: pyridine / acetonitrile / 20 - 45 °C
3.1: calcium oxide / xylene / 140 °C
4.1: sodium hydrogen sulfate; copper(l) iodide; sulfuric acid; potassium tert-butylate / diethylene glycol dimethyl ether / 115 °C
View Scheme
C8H12BrNO5

C8H12BrNO5

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: ammonium hydroxide / 5 h / 40 - 45 °C
2: trichlorophosphate / 1,2-dichloro-ethane / 8 h / 70 - 75 °C
3: 5 h / 60 - 65 °C
4: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
5: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
C15H16N4O2

C15H16N4O2

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
With benzenesulfonic acid at 90 - 95℃; for 6h; Reagent/catalyst;12.6 g
C8H12ClNO5

C8H12ClNO5

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: ammonium hydroxide / 5 h / 50 - 55 °C
2: trichlorophosphate / 1,2-dichloro-ethane / 8 h / 70 - 75 °C
3: 5 h / 60 - 65 °C
4: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
5: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
4-Methyl-3-nitro-2-pyridone
21901-18-8

4-Methyl-3-nitro-2-pyridone

Nevirapine
129618-40-2

Nevirapine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: trichlorophosphate / 1,2-dichloro-ethane / 8 h / 70 - 75 °C
2: 5 h / 60 - 65 °C
3: 5%-palladium/activated carbon; hydrogen / ethanol; toluene / 6 h / 30 - 35 °C / 1500.15 - 2250.23 Torr / Autoclave
4: benzenesulfonic acid / 6 h / 90 - 95 °C
View Scheme
silver(I) acetate
563-63-3

silver(I) acetate

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-4-methyl-6-oxo-6,11-dihydro-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-2-yl acetate
1350539-29-5

11-cyclopropyl-4-methyl-6-oxo-6,11-dihydro-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-2-yl acetate

Conditions
ConditionsYield
With iodine In dichloromethane at 104℃; for 0.0833333h;100%
formaldehyd
50-00-0

formaldehyd

1-(4-Nitrophenyl)piperazine
6269-89-2

1-(4-Nitrophenyl)piperazine

Nevirapine
129618-40-2

Nevirapine

5-cyclopropyl-9-methyl-10-[4-(4-nitro-phenyl)-piperazin-1-ylmethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

5-cyclopropyl-9-methyl-10-[4-(4-nitro-phenyl)-piperazin-1-ylmethyl]-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;92%
formaldehyd
50-00-0

formaldehyd

4-phenyl-1-piperazine
92-54-6

4-phenyl-1-piperazine

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-4-methyl-5-[(4-phenylpiperazin-1-yl)methyl]-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

11-cyclopropyl-4-methyl-5-[(4-phenylpiperazin-1-yl)methyl]-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;91%
formaldehyd
50-00-0

formaldehyd

4-(4-chlorophenyl) piperazine
38212-33-8

4-(4-chlorophenyl) piperazine

Nevirapine
129618-40-2

Nevirapine

5-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

5-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;89%
formaldehyd
50-00-0

formaldehyd

1-(4-methoxyphenyl)piperazine
38212-30-5

1-(4-methoxyphenyl)piperazine

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

11-cyclopropyl-5-{[4-(4-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;86%
formaldehyd
50-00-0

formaldehyd

1-phenylmethylpiperazine
2759-28-6

1-phenylmethylpiperazine

Nevirapine
129618-40-2

Nevirapine

5-[(4-benzylpiperazin-1-yl)methyl]-11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

5-[(4-benzylpiperazin-1-yl)methyl]-11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;83%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

formaldehyd
50-00-0

formaldehyd

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-4-methyl-5-[4-methylpiperazin-1-yl]methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

11-cyclopropyl-4-methyl-5-[4-methylpiperazin-1-yl]methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;80%
Nevirapine
129618-40-2

Nevirapine

6-chloro-11-cyclopropyl-4-methyl-11H-dipyrido[3,2-b:2',3'-e][1,4]diazepine

6-chloro-11-cyclopropyl-4-methyl-11H-dipyrido[3,2-b:2',3'-e][1,4]diazepine

Conditions
ConditionsYield
With N,N-dimethyl-aniline; trichlorophosphate at 110℃; for 8h;80%
In toluene
formaldehyd
50-00-0

formaldehyd

Nevirapine
129618-40-2

Nevirapine

1-(4-Fluorophenyl)piperazine
2252-63-3

1-(4-Fluorophenyl)piperazine

5-cyclopropyl-10-[4-(4-fluoro-phenyl)-piperazin-1-ylmethyl]-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

5-cyclopropyl-10-[4-(4-fluoro-phenyl)-piperazin-1-ylmethyl]-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;78%
triethyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)silane
745783-97-5

triethyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)silane

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-4-methyl-9-(triethylsilyl)-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

11-cyclopropyl-4-methyl-9-(triethylsilyl)-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Conditions
ConditionsYield
With 1,2-dimethoxyethane; potassium hexamethylsilazane for 3h; Inert atmosphere; regioselective reaction;74%
formaldehyd
50-00-0

formaldehyd

Nevirapine
129618-40-2

Nevirapine

N-(m-chlorophenyl)piperazine
6640-24-0

N-(m-chlorophenyl)piperazine

10-[4-(3-chloro-phenyl)-piperazin-1-ylmethyl]-5-cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

10-[4-(3-chloro-phenyl)-piperazin-1-ylmethyl]-5-cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;69%
piperazine
110-85-0

piperazine

formaldehyd
50-00-0

formaldehyd

Nevirapine
129618-40-2

Nevirapine

5-cyclopropyl-9-methyl-10-piperazin-1-ylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

5-cyclopropyl-9-methyl-10-piperazin-1-ylmethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

Conditions
ConditionsYield
In ethanol Mannich reaction; Irradiation; microwave;68%
Nevirapine
129618-40-2

Nevirapine

d8-11-cyclopropyl-4-methyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one
1051418-86-0

d8-11-cyclopropyl-4-methyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one

Conditions
ConditionsYield
With water-d2; sodium formate; palladium 10% on activated carbon In 1,4-dioxane at 200℃; for 48h;58%
Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one
133627-24-4

11-cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one

Conditions
ConditionsYield
With oxygen; lithium diisopropyl amide In tetrahydrofuran Ambient temperature;31%
With MoO5*pyridine*HMPA; lithium diisopropyl amide Product distribution; multistep reaction; influence of base;
With MoO5*pyridine*HMPA; lithium diisopropyl amide 1.) THF, hexane, below -40 deg C, 5 min, 2.) -30 to -40 deg C, 75 min; Yield given. Multistep reaction;
With MoO5*pyridine*HMPA; lithium diisopropyl amide 1.) THF, hexane, -30 deg C, 5 min, 2.) THF, hexane, -30 deg C, 1.5 h; Yield given. Multistep reaction;
Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5,11-dihydro-4-methyl-3-nitro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
284686-16-4

11-cyclopropyl-5,11-dihydro-4-methyl-3-nitro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Conditions
ConditionsYield
With nitronium tetrafluoborate; 4 A molecular sieve In acetonitrile at 0℃; for 20h; Nitration;20%
Nevirapine
129618-40-2

Nevirapine

A

5-Cyclopropyl-9-methyl-4-oxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

5-Cyclopropyl-9-methyl-4-oxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

B

5-Cyclopropyl-9-methyl-6-oxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

5-Cyclopropyl-9-methyl-6-oxy-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

C

11-cyclopropyl-5,11-dihydro-4-methyl-8-hydroxy-1,10-dioxy-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one

11-cyclopropyl-5,11-dihydro-4-methyl-8-hydroxy-1,10-dioxy-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one

Conditions
ConditionsYield
With dihydrogen peroxide; acetic acid at 95℃; for 18h;A 0.9%
B 17%
C 9%
Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-7-iodo-4-methyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one
1227201-82-2

11-cyclopropyl-7-iodo-4-methyl-5H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6(11H)-one

Conditions
ConditionsYield
Stage #1: Nevirapine With dilithium magnesium bis(2,2,6,6-tetramethylpiperidin-1-ide) dichloride In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
Stage #2: With iodine In tetrahydrofuran at 0 - 20℃; Inert atmosphere;
10%
oxodiperoxymolybdenum(pyridine)hexamethylphosphoramide

oxodiperoxymolybdenum(pyridine)hexamethylphosphoramide

Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5,11-dihydro-5-hydroxy-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one
135794-73-9

11-cyclopropyl-5,11-dihydro-5-hydroxy-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one

Conditions
ConditionsYield
In tetrahydrofuran; mineral oil9.5%
sodium 7‐azido‐1,1‐difluoroheptane‐1‐sulfinate

sodium 7‐azido‐1,1‐difluoroheptane‐1‐sulfinate

Nevirapine
129618-40-2

Nevirapine

A

C22H25F2N7O
1450912-75-0

C22H25F2N7O

B

C22H25F2N7O
1450912-76-1

C22H25F2N7O

C

C22H25F2N7O
1450912-74-9

C22H25F2N7O

Conditions
ConditionsYield
With tert.-butylhydroperoxide; trifluoroacetic acid; zinc(II) chloride In water; dimethyl sulfoxide at 50℃; for 11h; Cooling with ice;A 8%
B 9%
C 9%
Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5,11-dihydro-8-hydroxy-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

11-cyclopropyl-5,11-dihydro-8-hydroxy-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Conditions
ConditionsYield
Stage #1: Nevirapine With dihydrogen peroxide; acetic acid at 95 - 100℃; for 48h; Oxidation;
Stage #2: With hydrogen; palladium on activated charcoal In ethyl acetate under 2068.59 Torr; for 6h; Reduction;
5%
Nevirapine
129618-40-2

Nevirapine

11-cyclopropyl-5,11-dihydro-5-hydroxy-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one
135794-73-9

11-cyclopropyl-5,11-dihydro-5-hydroxy-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepin-6-one

Conditions
ConditionsYield
With MoO5*pyridine*HMPA; sodium hydride 1.) THF, r.t., 1 h, 2.) 0 deg C to r.t., 2 d; Yield given. Multistep reaction;
Nevirapine
129618-40-2

Nevirapine

phenyldimethylsilyl chloride
768-33-2

phenyldimethylsilyl chloride

A

11-cyclopropyl-5,11-dihydro-4-<(dimethylphenylsilyl)methyl>-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one
141319-44-0

11-cyclopropyl-5,11-dihydro-4-<(dimethylphenylsilyl)methyl>-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one

B

11-cyclopropyl-5,11-dihydro-7-(dimethylphenylsilyl)-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one
141319-45-1

11-cyclopropyl-5,11-dihydro-7-(dimethylphenylsilyl)-4-methyl-6H-dipyrido<3,2-b:2',3'-e><1,4>diazepine-6-one

Conditions
ConditionsYield
Product distribution; multistep reaction; reaction of nevirapine with phenyldimethylchlorosilane;
Yield given. Multistep reaction. Yields of byproduct given;
Nevirapine
129618-40-2

Nevirapine

methyl iodide
74-88-4

methyl iodide

5-Cyclopropyl-9,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one
133627-19-7

5-Cyclopropyl-9,10-dimethyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo[a,d]cyclohepten-11-one

Conditions
ConditionsYield
With sodium hydride 1.) DMSO, 2.) DMSO; Multistep reaction;
Stage #1: Nevirapine With sodium hydride In N,N-dimethyl-formamide at 60℃; for 2h;
Stage #2: methyl iodide In N,N-dimethyl-formamide at 20℃; for 2h;
Nevirapine
129618-40-2

Nevirapine

2-amino-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
284686-15-3

2-amino-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 20 percent / 4A molecular sieves; nitronium tetrafluoroborate / acetonitrile / 20 h / 0 °C
2: 86 percent / tin(II) chloride; conc. aq. HCl; acetic acid / 20 °C
View Scheme

Nevirapine Chemical Properties

Molecular structure of Nevirapine (CAS NO.129618-40-2) is:

Product Name: Nevirapine
CAS Registry Number: 129618-40-2
Molecular Weight: 266.29786 [g/mol]
Molecular Formula: C15H14N4O
XLogP3-AA: 2
H-Bond Donor: 1
H-Bond Acceptor: 4
Melting Point: 247 °C
Surface Tension: 66.3 dyne/cm
Density: 1.351 g/cm3
Flash Point: 205 °C
Enthalpy of Vaporization: 66.85 kJ/mol
Boiling Point: 415.4 °C at 760 mmHg
Vapour Pressure: 4.13E-07 mmHg at 25°C
Product Categories: Active Pharmaceutical Ingredients;API;Anti-virals;Inhibitors;Intermediates & Fine Chemicals;Non-nucleoside Reverse Transcriptase;Pharmaceuticals

Nevirapine History

 Nevirapine (CAS NO.129618-40-2) was discovered by Hargrave et al. at Boehringer Ingelheim Pharmaceuticals, Inc., one of the Boehringer Ingelheim group of companies. It is covered by U.S. Patent 5,366,972 and corresponding foreign patents. It was the first NNRTI approved by the U.S. Food and Drug Administration (FDA). It was approved June 21, 1996 for adults and September 11, 1998 for children. It was also approved in Europe in 1997.

Nevirapine Uses

 Nevirapine (CAS NO.129618-40-2) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.

Nevirapine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 3200mg/kg (3200mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 2209, 1999.
rat LDLo oral 400mg/kg (400mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 2209, 1999.

Nevirapine Safety Profile

Hazard Codes: IrritantXi
Risk Statements: 36/37/38 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36-37/39
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing. 
S37/39:Wear suitable gloves and eye/face protection.

Nevirapine Specification

 Nevirapine , its cas register number is 129618-40-2. It also can be called Viramune ; 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one ; 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- .It is a crystalline solid. It has also been tested in trials in Africa, some of which have been highly controversial.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View